Phio Pharmaceuticals Corp. (PHIO) stock

PHIONasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 5/30

$0.81−0.00 (-0.17%)

Close on Nov 12, 2026Market cap $9.43MP/E –Yield –

Phio Pharmaceuticals gross margin

Gross margin is gross profit as a percentage of revenue.

Phio Pharmaceuticals has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

See a number that looks wrong?